School of Medicine
Showing 1-10 of 59 Results
Professor of Radiation Oncology (Radiation Biology) and of Genetics
Current Research and Scholarly Interests Our research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
Instructor, Radiation Oncology - Radiation Physics
Current Research and Scholarly Interests I am interested in ) treatment planning for small animal radiotherapy, 2) x-ray fluorescence CT (XFCT) imaging for high-sensitivity molecular imaging, and 3) novel concept of radiation therapy with very high-energy electron (VHEE) beams.
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly Interests We seek to understand the mechanisms responsible for the resistance of cancers to treatment and to develop strategies to overcome these resistances. We are using molecular and cellular techniques and mouse models to potentiate the activity of radiation on tumors by inhibiting the bone marrow rescue of the tumor vasculature following therapy.
Associate Professor of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center
Current Research and Scholarly Interests I specialize in the treatment of gastrointestinal malignancies. I am interested in developing stereotactic body radiotherapy for tumors of the liver, both primary and metastatic. I am interested in developing functional imaging as a means of determining treatment response with radiation. I am also interested in developing image-guided radiotherapy to improve radiation delivery for GI cancers to reduce toxicity and improve disease outcome.
Maximilian Diehn, MD, PhD
Assistant Professor of Radiation Oncology
Current Research and Scholarly Interests My laboratory focuses on two main areas: 1) cancer stem cell biology and 2) novel biomarkers for identifying the presence of malignant cells (diagnostic), predicting outcome (prognostic), and predicting response to therapy (predictive). Areas of study include cancers of the lung, breast, and gastrointestinal system. Clinically I specialize in the treatment of lung cancer and applications of stereotactic ablative radiotherapy and perform both prospective and retrospective clinical studies.
Sarah S. Donaldson, MD
Catharine and Howard Avery Professor in the School of Medicine
Current Research and Scholarly Interests Combined Modality Treatment of Cancer
Late Effects of Treatment
Genetic Effects of Cancer
Pediatric Radiation Oncolgy
Radiotherapy for Benign Diseases